dofequidar has been researched along with Carcinoma, Small Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doyle, LA; Fukuda, M; Ikeda, K; Kohno, S; Nakamura, T; Nakano, R; Narasaki, F; Oka, M; Soda, H; Takatani, H; Terashi, K; Tsuruo, T; Yano, O | 1 |
| Hanibuchi, M; Parajuli, P; Shrivastava, P; Sone, S; Tsuruo, T; Yano, S | 1 |
| Hanibuchi, M; Higasida, T; Nishioka, Y; Nokihara, H; Sone, S; Tsuruo, T; Yano, S | 1 |
3 other study(ies) available for dofequidar and Carcinoma, Small Cell
| Article | Year |
|---|---|
A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lung Neoplasms; Quinolines; Tumor Cells, Cultured | 1997 |
Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lung Neoplasms; Quinolines; Tumor Cells, Cultured; Verapamil | 1998 |
A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Neoplasm Metastasis; Quinolines; Vincristine; Xenograft Model Antitumor Assays | 2001 |